1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 81-3-5375-6097
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Gene expression signature for recurrence in stage III colorectal cancers
Article first published online: 17 NOV 2008
DOI: 10.1002/cncr.24023
Copyright © 2008 American Cancer Society
Additional Information
How to Cite
Watanabe, T., Kobunai, T., Sakamoto, E., Yamamoto, Y., Konishi, T., Horiuchi, A., Shimada, R., Oka, T. and Nagawa, H. (2009), Gene expression signature for recurrence in stage III colorectal cancers. Cancer, 115: 283–292. doi: 10.1002/cncr.24023
Publication History
- Issue published online: 7 JAN 2009
- Article first published online: 17 NOV 2008
- Manuscript Accepted: 13 AUG 2008
- Manuscript Revised: 6 AUG 2008
- Manuscript Received: 11 FEB 2008
References
- 1,,, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001; 344: 1196–1206.
- 2,,,. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol. 2001; 62: 1311–1336.
- 3,. Application of DNA microarrays in pharmacogenomics and toxicogenomics. Pharm Res. 2002; 19: 1773–1778.
- 4,,, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene-expression profiles. Cancer Res. 2006; 66: 3370–3374.
- 5,,, et al. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res. 2007; 13: 415–420.
- 6,,, et al. Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res. 2006; 66: 9804–9808.
- 7,,, et al. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat. 2005; 26: 540–549.Direct Link:
- 8,. Nearest neighbor pattern classification. IEEE Trans Inf Theory. 1967; 13: 21–27.
- 9,,, et al. Digital karyotyping. Proc Natl Acad Sci U S A. 2002; 99: 16156–16161.
- 10,,, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 2004; 64: 3060–3071.
- 11,,, et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology. 2005; 129: 874–884.
- 12,,, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 1993; 104: 57–64.
- 13,,, et al. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology. 1993; 104: 1044–1048.
- 14,,. p53 point mutation and survival in colorectal cancer patients. Cancer Res. 1995; 55: 5217–5221.
- 15,,,. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. 1996; 13: 63–72.
- 16,. Array comparative genomic hybridization and its applications in cancer. Nat Genet. 2005; 37( suppl): S11–S17.
- 17. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res. 2000; 463: 247–283.
- 18,,, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994; 300: 271–276.
- 19,,, et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer. 1999; 84: 135–138.Direct Link:
- 20,. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity. 2000; 13: 85–94.